AVITA MEDICAL INC (RCEL) Stock Balance Sheet
NASDAQ:RCEL • US05380C1027
Current stock price
3.86 USD
-0.13 (-3.26%)
At close:
3.86 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 10.24M | N/A | 22.12M | 18.20M | 110.70M | |||
| Marketable Securities | 7.94M | 21.84M | 66.94M | 61.20M | 29.60M | |||
| Receivables | 9.09M | 11.84M | 7.94M | 5.00M | 7.90M | |||
| Inventories | 6.93M | 7.27M | 5.60M | 2.10M | 1.60M | |||
| Other Current Assets | 1.29M | 2.00M | 1.41M | 1.00M | 1.10M | |||
| Total Current Assets | 35.49M | 57.00M | 104.01M | 87.50M | 121.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.53M | 13.59M | 4.32M | 2.10M | 2.90M | |||
| Investments And Advances | N/A | N/A | N/A | 6.90M | 19.70M | |||
| Intangibles | 5.64M | 5.57M | 487.00K | 500.00K | 500.00K | |||
| Other Non-Current Assets | 3.73M | 3.55M | 2.83M | 1.40M | 800.00K | |||
| Total Non-Current Assets | 20.90M | 22.71M | 7.63M | 10.80M | 4.20M | |||
| TOTAL ASSETS | 56.39M | 79.71M | 111.64M | 98.30M | 125.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 42.98M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.74M | 11.35M | 8.87M | 7.20M | 4.00M | |||
| Accounts Payable | 8.96M | 6.29M | 3.79M | 3.00M | 3.10M | |||
| Other Current Liabilities | 1.99M | 2.51M | 539.00K | 500.00K | 200.00K | |||
| Total Current Liabilities | 62.68M | 20.16M | 13.20M | 10.70M | 7.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 42.24M | 39.81M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 10.37M | 12.81M | 9.57M | 2.80M | 2.50M | |||
| Total Non-Current Liabilities | 10.37M | 55.05M | 49.38M | 2.80M | 2.40M | |||
| TOTAL LIABILITIES | 73.04M | 75.21M | 62.58M | 13.50M | 9.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -408.40M | -359.81M | -297.97M | -262.60M | -221.50M | |||
| Additional Paid In Capital | 394.41M | 367.57M | 350.04M | 339.80M | 328.90M | |||
| Common Shares | 3.00K | 3.00K | 3.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -2.66M | -3.26M | -3.02M | 7.50M | 8.30M | |||
| Shares Outstanding | 30.57M | 26.35M | 25.68M | 25.20M | 24.90M | |||
| Tangible Book Value per Share | -0.73 | -0.04 | 1.89 | 3.34 | 4.63 | |||
| Total Shareholders' Equity | -16.65M | 4.50M | 49.06M | 84.70M | 115.70M | |||
| TOTAL LIABILITIES AND EQUITY | 56.39M | 79.71M | 111.64M | 98.30M | 125.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 9.39 | 0.81 | N/A | N/A | |||
| Current Ratio | 0.57 | 2.83 | 7.88 | 8.18 | 16.39 | |||
| Return On Assets (ROA) | -86.16% | -77.59% | -31.69% | -27.13% | -21.18% | |||
| Return On Equity (ROE) | N/A | -1374.64% | -72.12% | -31.49% | -22.97% | |||
All data in USD , ROIC based on taxRate of 0.21